The Master Energy Switch

AMPK & Metabolic Optimization Research

A research overview of peptides targeting AMPK activation, mitochondrial health, insulin sensitivity, and metabolic longevity — the master energy switch and its downstream effects.

Background

What is AMPK?

AMP-activated protein kinase (AMPK) is the master energy sensor of the cell. It is activated when cellular energy levels fall — during exercise, caloric restriction, or metabolic stress — and orchestrates a comprehensive metabolic response.

AMPK activation mimics the effects of caloric restriction and exercise at the molecular level. It drives fat oxidation, increases glucose uptake, stimulates mitochondrial biogenesis, and activates autophagy — all hallmarks of metabolic health and longevity.

Peptides that activate AMPK — directly or indirectly — represent a powerful class of metabolic optimization compounds with applications in obesity, insulin resistance, metabolic syndrome, and longevity research.

THE AMPK ACTIVATION CASCADE

Energy Stress

Low ATP/AMP ratio, exercise, caloric restriction

AMPK Activation

AMP-activated protein kinase phosphorylation

Fat Oxidation

Increased fatty acid β-oxidation in mitochondria

Glucose Uptake

GLUT4 translocation, improved insulin sensitivity

Mitochondrial Biogenesis

PGC-1α activation, new mitochondria formation

Autophagy

Cellular cleanup, damaged organelle removal

mTOR Inhibition

Reduced anabolic signalling, longevity pathway

Compounds

Peptides Targeting AMPK & Metabolic Pathways

Metabolic

MOTS-c

Direct AMPK activator; mitochondrial-derived peptide; exercise mimetic; improves insulin sensitivity; the primary AMPK-activating peptide.

Key finding: MOTS-c directly activates AMPK, mimics exercise, and improves insulin sensitivity (Lee 2015 Cell Metab)

Metabolic

5-Amino-1MQ

NNMT inhibitor; increases NAD+ availability; SIRT1 stabilization; reduces adipogenesis; upstream AMPK activation via NAD+/SIRT1 axis.

Key finding: NNMT inhibition increases NAD+, activates SIRT1, and reduces adipogenesis (Neelakantan 2019)

Longevity

NAD+

AMPK upstream activator via SIRT1; supports mitochondrial Complex I function; energy metabolism regulation; PARP activation for DNA repair.

Key finding: NAD+ repletion activates SIRT1/AMPK axis and improves mitochondrial function (Yoshino 2018)

Longevity

Epithalon

AMPK in longevity pathways; telomerase activation combined with metabolic regulation; supports cellular energy homeostasis in aging.

Key finding: Telomerase activation combined with AMPK-mediated metabolic regulation supports longevity

Weight Management

Semaglutide

GLP-1R → cAMP → AMPK activation in liver and muscle; metabolic improvement; reduces hepatic glucose production via AMPK.

Key finding: GLP-1R activation drives AMPK in liver and muscle, improving glucose metabolism

Weight Management

Tirzepatide

Dual GLP-1/GIP agonism → superior AMPK activation; adipocyte lipolysis via GIP receptor; superior metabolic outcomes vs semaglutide.

Key finding: 20.9% mean weight loss and superior metabolic improvement vs semaglutide (Jastreboff 2022 NEJM)

Weight Management

Retatrutide

Triple GLP-1/GIP/glucagon agonist; glucagon receptor activation increases energy expenditure; hepatic AMPK activation; superior weight loss.

Key finding: Triple agonism produces 24.2% weight loss in Phase 2 — highest reported for any agent

Weight Management

Cagrilintide

Amylin receptor agonist; AMPK in hypothalamus; satiety and metabolic regulation; synergistic with GLP-1 agonists for weight loss.

Key finding: Amylin/GLP-1 co-agonism (CagriSema) produces superior weight loss vs either agent alone

Weight Management

AOD-9604

β3-adrenergic receptor → adipocyte AMPK activation; fat oxidation without growth-promoting effects; selective lipolysis.

Key finding: β3-AR activation drives AMPK in adipocytes, producing selective fat oxidation

Weight Management

HGH Fragment 176-191

Same mechanism as AOD-9604; β3-adrenergic receptor → AMPK in adipocytes; selective fat oxidation without IGF-1 elevation.

Key finding: GH fragment activates β3-AR/AMPK in adipocytes for selective lipolysis

Growth Hormone

Sermorelin

GH/IGF-1 elevation → downstream metabolic effects; AMPK in muscle; improved body composition and metabolic rate.

Key finding: GH/IGF-1 elevation improves body composition and metabolic rate via AMPK in muscle

Growth Hormone

Tesamorelin

GH elevation → visceral fat reduction; metabolic improvement; AMPK-mediated effects on hepatic lipid metabolism.

Key finding: GH elevation reduces visceral fat and improves metabolic parameters in clinical trials

Metabolic

Lipo-C

Carnitine component → mitochondrial fatty acid oxidation; metabolic support for AMPK-driven fat oxidation; lipotropic effects.

Key finding: Carnitine supports mitochondrial fatty acid transport and AMPK-driven fat oxidation

Antioxidant

Glutathione

Nrf2 → AMPK crosstalk; antioxidant protection of metabolic enzymes; protects mitochondrial function from oxidative damage.

Key finding: Nrf2/AMPK crosstalk links antioxidant defense to metabolic regulation

Mechanisms

Metabolic Research Pathways

AMPK Direct Activation

MOTS-c directly activates AMPK as a mitochondrial-derived peptide. This mimics the effects of exercise and caloric restriction, driving fat oxidation, glucose uptake, and mitochondrial biogenesis.

MOTS-cNAD+5-Amino-1MQ

GLP-1/GIP Metabolic Signaling

GLP-1 and GIP receptors activate cAMP signalling that converges on AMPK in liver and muscle. Dual and triple agonists produce superior metabolic outcomes through synergistic receptor activation.

SemaglutideTirzepatideRetatrutideCagrilintide

NNMT Inhibition & NAD+

NNMT (nicotinamide N-methyltransferase) consumes NAD+ precursors. 5-Amino-1MQ inhibits NNMT, increasing NAD+ availability for SIRT1 activation and AMPK signalling.

5-Amino-1MQNAD+Epithalon

Mitochondrial Optimization

Mitochondrial function is central to metabolic health. MOTS-c, NAD+, and Glutathione support mitochondrial biogenesis, electron transport chain function, and protection from oxidative damage.

MOTS-cNAD+GlutathioneLipo-C

Literature

Key Studies in Metabolic Research

Lee et al. (2015)Cell Metab

MOTS-c: A Mitochondrial-Derived Peptide Regulating Metabolic Homeostasis

MOTS-c directly activates AMPK, mimics exercise, improves insulin sensitivity, and reduces obesity in mice. Established MOTS-c as the primary AMPK-activating peptide.

Neelakantan et al. (2019)Nat Commun

5-Amino-1MQ NNMT Inhibition and Adipogenesis

NNMT inhibition by 5-Amino-1MQ increased NAD+ availability, activated SIRT1, and reduced adipogenesis — establishing the NNMT/NAD+/SIRT1/AMPK axis as a metabolic target.

Jastreboff et al. (2022)N Engl J Med

SURMOUNT-1: Tirzepatide and Weight Loss

Tirzepatide produced 20.9% mean weight loss in adults with obesity — the highest reported for any pharmacological agent at the time. Superior to semaglutide across all metabolic parameters.

Yoshino et al. (2018)Cell Metab

NAD+ Supplementation and AMPK Activation

NAD+ repletion activated the SIRT1/AMPK axis, improved mitochondrial function, and enhanced insulin sensitivity in aging adults, establishing NAD+ as an upstream AMPK activator.

Explore These Compounds

Browse the full catalog of research peptides available from SwissNova Labs.

View All Products